Market open· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
AkzoNobel (AKZOY) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
AKZOY vs. APD: Which Stock Is the Better Value Option?
Akzo Nobel stock has delivered a decline of almost 30% over the past 5 years, yet current valuation checks suggest the shares may now trade at a discount to their estimated intrinsic value. With both a Discounted Cash Flow (DCF) estimate and market multiples pointing in the same direction, investors are weighing whether that gap is meaningful or a value trap. The roughly 29.6% share price decline over 5 years means long term holders have seen capital erode, which can sometimes leave a stock...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.